![Natasha Hernday](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 717 943 $ in data 31/05/2026
Natasha A. Hernday is an Independent Director at XOMA Royalty Corp.
since 2020 and an Independent Director at Janux Therapeutics, Inc. since 2024.
Former roles include Director-Mergers, Acquisitions & Out-Partnering at Amgen, Inc. from 1994 to 2010, Independent Director at PDL BioPharma, Inc. from 2019 to 2022, Independent Director at Alpine Immune Sciences, Inc. from 2020 to 2024, and Chief Business Officer at Seagen, Inc. from 2022 to 2023.
Education includes an MBA from Pepperdine University and undergraduate studies at the University of California, Santa Barbara.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/05/2026 | 12.592 ( 0,1% ) | 525 212 $ | 31/05/2026 | |
| 21/05/2026 | 4.000 ( 0,41% ) | 101 820 $ | 31/05/2026 | |
| 11/06/2026 | 6.231 ( 0,01% ) | 90 910 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| XOMA ROYALTY CORPORATION | Direttore/Membro del Consiglio | 30/06/2020 |
| JANUX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/07/2024 |
| Società | Posizione | Fine |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Direttore/Membro del Consiglio | 20/05/2024 |
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2023 |
| PDL BIOPHARMA, INC. | Direttore/Membro del Consiglio | 01/12/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2010 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
